Aclidinium Bromide
| Use attributes for filter ! | |
| Molar mass | 564. 555 g/mol |
|---|---|
| Trade name | Bretaris Genuair, Eklira Genuair, Tudorza Pressair |
| Duration of action | >24 hrs |
| ATC code | R03BB05 (WHO) |
| Elimination half-life | 2–3 hrs |
| License data | FDA |
| Music groups | Tiotropium bromide |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2072191 |
About Aclidinium Bromide
Aclidinium bromide is a long-acting, inhaled muscarinic antagonist approved in the US on July 24, 2012 as a maintenance treatment for chronic obstructive pulmonary disease. Evidence shows that it can improve quality of life and prevent hospitalization in those with COPD.